Synthesis and evaluation of the antibacterial and antifungal activity of new ibuprofen hydrazone derivatives

Year 2024, Volume: 54 Issue: 2, 122 - 127, 26.08.2024

Çağla Begüm Apaydın , Emel Mataracı Kara

https://doi.org/10.26650/IstanbulJPharm.2024.1444072

Abstract

Background and Aims: The pursuit of new antimicrobial agents to address antimicrobial resistance remains a fundamental effort in supporting sustainable global health endeavours. Hydrazone compounds possess numerous advantages as biologically active agents because of their diverse properties. In our work, a series of hydrazone derivatives (4a-f) containing the ibuprofen moiety were synthesised and evaluated as antibacterial and antifungal agents.

Methods: Novel hydrazone derivatives were synthesised through the condensation of 2-[4-(2 methylpropyl)phenyl]propanehydrazide with suitable cyclohexanone derivatives. The structure of the new compounds was confirmed using spectral methods such as IR, 1H-NMR, 13C-NMR (APT) and electrospray ionisation mass spectrometry (ESI-MS). Testing involved six compounds and their standards against a range of bacterial and fungal strains, including Gram-positive and Gram-negative bacteria, as well as Candida spp. MIC values were determined using the microbroth dilution method.

Results: Each of the tested molecules exhibited varying inhibitory effects across six distinct targets, resulting in different MIC values. Compounds 4a, 4e, and 4f showed moderate antimicrobial activity compared with the standards.

Conclusion: Among the tested compounds, compound 4a demonstrated the most potent antimicrobial activity against the P. mirabilis strain, with an MIC value of 312.5 μg/mL. Further modification and development of ibuprofen-hydrazone derivatives against targets may result in new antimicrobial drug candidates in the near future.

Keywords

Hydrazone, ibuprofen, antibacterial activity, antifungal activity, gram-positive bacteria, gram-negative bacteria

References

• Allegretti, M., Bertini, R., Candida, M.C., Bizzarri, C., Di Bitondo, R., Di Cioccio, . . . Colotta, F. (2005). 2-Arylpropionic CXC Chemokine Receptor 1 (CXCR1) Ligands as Novel Noncompeti-tive CXCL8 Inhibitors, Journal of Medicinal Chemistry, 48, 4312-https://doi.org/4331. 10.1021/jm049082i. google scholar
• Angelova, V., Karabeliov, V., Andreeva-Gateva, P.A., Tchekalarova, J. (2016). Recent Developments of Hydrazide/Hydrazone Deriva-tives and Their Analogs as Anticonvulsant Agents in Ani-mal Models. Drug Development Research, 77(7), 379-392. https://doi.org/10.1002/ddr.21329. google scholar
• Antimicrobial resistance 2023. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance (accessed Jan 27, 2023). google scholar
• Apaydın, Ç.B., Hasbal Çelikok, G., Yılmaz Özden, T., Cihan Üstündağ, G. (2022). Design, synthesis and biological evalua-tion of novel sulfonamide hydrazones as a-glucosidase and a-amylase inhibitors. İstanbul Journal of Pharmacy, 52(2), 108-113. https://doi.org/10.26650/IstanbulJPharm.2022.1018698. google scholar
• Bülbül, B., Ding, K., Zhan, C., Çiftçi, G., Yelekçi, K., Gürboğa, M., . . . Küçükgüzel, İ. (2023). Novel 1,2,4-triazoles derived from Ibuprofen: synthesis and in vitro evaluation of their mPGES-1 inhibitory and antiproliferative activity, Molecular Diversity, 27, 2185-2215. https://doi.org/10.1007/s11030-022-10551-0. google scholar
• Cihan Üstündağ, G., Mataracı Kara, E., Çapan G. (2019). Synthesis, characterization, antibacterial and antifungal evaluation of novel cyclohexanone benzoylhydrazones. İstanbul Journal of Phar-macy, 49(3): 142-147. https://doi.org/10.26650/istanbuljpharm. 2019.19022. google scholar
• CLSI, Clinical and Laboratory Standards Institute Performance Stan-dards for Antimicrobial Susceptibility Testing, Clinical and Lab-oratory Standards Institute. 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087, USA, 2020. google scholar
• CLSI, Clinical and Laboratory Standards Institute Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard M27-A3.2008, Wayne, 2008. google scholar
• Dadgostar, P. (2019). Antimicrobial Resistance: Implications and Costs. Infection and Drug Resistance, 12, 3903-3910. https://doi.org/10.2147/IDR.S234610. google scholar
• Evranos-Aksöz, B., Gürpinar, S.S., Eryilmaz, M. (2020). Antimi-crobial activities of some pyrazoline and hydrazone derivatives. Turkish Journal Of Pharmaceutical Sciences, 17(5), 500-505. https://doi.org/10.4274/tjps.galenos.2019.42650. google scholar
• Koçyiğit-Kaymakçıoğlu, B., Elçin, O., Seda, U., Fatma, K., Nathaly, S., Sevim, R., Dimoglo, A. (2006). Synthe-sis and characterization of novel hydrazide-hydrazones and the study of their structure-antituberculosis activity. Euro-pean Journal of Medicinal Chemistry, 41(11), 1253-1261. https://doi.org/10.1016/j.ejmech.2006.06.009. google scholar
• Masunari, A., Tavares, L.C. (2007). A new class of nifuroxazide analogues: Synthesis of 5-nitrothiophene derivatives with an-timicrobial activity against multidrug-resistant Staphylococcus aureus. Bioorganic Medicinal Chemistry, 15(12): 4229-4236. https://doi.org/10.1016/j.bmc.2007.03.068. google scholar
• Moore, N. (2007). Ibuprofen: A Journey from Prescription to Over-the-Counter Use. Journal of the Royal Society of Medicine, 100, 2-6. https://doi.org/10.1177/014107680710004801s01. google scholar
• Nasr, T., Bondock, S., Youns, M. (2014). Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives. European Journal of Medicinal Chemistry, 76(9), 539-548. https://doi.org/10.1016/j.ejmech.2014.02.026. google scholar
• Obad, J., Suskovic, J., Kos, B. (2015). Antimicrobial activity of ibuprofen: New perspectives on an “Old” non-antibiotic drug. European Journal of Pharmaceutical Sciences, 71, 93-98. http://dx.doi.org/10.1016/j.ejps.2015.02.011. google scholar
• Paprocka, R., Wiese-Szadkowska, M., Helmin-Basa, A., Mazur, L., Kutkowska, J., Michalkiewicz, J., ... Pazderski, L. (2018). Syn-thesis and evaluation of new amidrazone-derived hydrazides as a potential anti-inflammatory agents. Monatshefte für Chemie, 149,1493-1500. https://doi.org/10.1007/s00706-018-2197-8. google scholar
• Salgin-Goksen, U., Telli, G., Erikci, A., Dedecengiz, E., Tel, B.C., Kaynak, F.B., ... Gokhan-Kelekci, N. (2021). New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors. Journal of Medicinal Chemistry, 64(4): 1989-2009. https://doi.org/10.1021/acs.jmedchem.0c01504. google scholar
• Taha, M., Shah, S.A.A., Imran, S., Afifi, M., Chigurupati, S., Selvaraj, M., . . . Vijayabalan, S. (2017). Synthesis and in vitro study of benzofuran hydrazone derivatives as novel alpha-amylase inhibitor. Bioorganic Chemistry, 75, 78-85. https://doi.org/10.1016/j.bioorg.2017.09.002. google scholar
• Tatar, E., Şenkardeş, S., Sellitepe, H.E., Küçükgüzel, Ş.G., Karaoglu, Ş.A., Bozdeveci, A., De Clercq, E., Pannecouque, C., Ben Hadda, T., Küçükgüzel, I. (2016). Synthesis, and prediction of molecular properties and antimicrobial activity of some acylhydrazones de-rived from N-(arylsulfonyl)methionine. Turkish Journal of Chem-istry, 40(3), 510-534. https://doi.org/10.3906/kim-1509-21. google scholar
• Tian, B., He, M., Tang, S., Hewlett, I., Tan, Z., Li, J., . . . Yang, M. (2009). Synthesis and antiviral activities of novel acyl-hydrazone derivatives targeting HIV-1 capsid protein. Bioor-ganic & Medicinal Chemistry Letters, 19(8): 2162-2167. https://doi.org/10.1016/j.bmcl.2009.02.116. google scholar
• Vicini, P., Zani, F., Cozzini, P., Doytchinova, I. (2002). Hydrazones of 1,2-benzisothiazole hydrazides: Synthesis, antimicrobial ac-tivity and QSAR investigations. European Journal of Medic-inal Chemistry, 37(7), 553-564. https://doi.org/10.1016/S0223-5234(02)01378-8. google scholar